RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Edesa Biotech - Stock

Edesa Biotech ROA 2024

Edesa Biotech ROA

-0.94

Ticker

EDSA

ISIN

CA27966L1085

WKN

A2PL1Q

In 2024, Edesa Biotech's return on assets (ROA) was -0.94, a -37.85% increase from the -1.52 ROA in the previous year.

Edesa Biotech Aktienanalyse

What does Edesa Biotech do?

Edesa Biotech Inc is a Canadian-based company that focuses on the development of novel therapeutic drugs. The company was founded in 2015 and has since achieved numerous significant advancements and successes. Edesa Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Edesa Biotech's Return on Assets (ROA)

Edesa Biotech's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Edesa Biotech's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Edesa Biotech's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Edesa Biotech’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Edesa Biotech Stock

What is the Return on Assets (ROA) of Edesa Biotech this year?

The Return on Assets (ROA) of Edesa Biotech is -0.94 undefined this year.

What was the ROA of Edesa Biotech compared to the previous year?

The ROA of Edesa Biotech has increased by -37.85% compared to the previous year.

What consequences do high ROA have for investors of Edesa Biotech?

A high ROA is advantageous for investors of Edesa Biotech, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Edesa Biotech?

A low ROA can be unfavorable for investors of Edesa Biotech as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Edesa Biotech affect the company?

An increase in ROA of Edesa Biotech can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Edesa Biotech impact the company?

A reduction in the ROA of Edesa Biotech can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Edesa Biotech?

Some factors that can influence the ROA of Edesa Biotech include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Edesa Biotech important for investors?

The ROA of Edesa Biotech is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Edesa Biotech take to improve ROA?

To improve ROA, Edesa Biotech can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Edesa Biotech pay?

Over the past 12 months, Edesa Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Edesa Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Edesa Biotech?

The current dividend yield of Edesa Biotech is .

When does Edesa Biotech pay dividends?

Edesa Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Edesa Biotech?

Edesa Biotech paid dividends every year for the past 0 years.

What is the dividend of Edesa Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Edesa Biotech located?

Edesa Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Edesa Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Edesa Biotech from 6/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Edesa Biotech pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of Edesa Biotech in the year 2023?

In the year 2023, Edesa Biotech distributed 0 USD as dividends.

In which currency does Edesa Biotech pay out the dividend?

The dividends of Edesa Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Edesa Biotech

Our stock analysis for Edesa Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Edesa Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.